Holen Sie sich die Stockscreener-App
4.71
9.28%
0.40
Handel nachbörslich:
4.71
Schlusskurs vom Vortag:
$4.31
Offen:
$4.32
24-Stunden-Volumen:
493.56K
Relative Volume:
1.22
Marktkapitalisierung:
$85.50M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-1.7065
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
+6.08%
1M Leistung:
-63.12%
6M Leistung:
-75.62%
1J Leistung:
-73.61%
1-Tages-Spanne:
$4.16
$4.79
1-Wochen-Bereich:
$4.00
$4.79
52-Wochen-Spanne:
$4.00
$25.35
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.71 | 78.24M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Can Outset Medical Inc. stock outperform in 2025 bull marketTrade Ideas & Growth Focused Entry Reports - Newser
Virtual Meeting for OM Scheduled by BTIG - GuruFocus
Can Outset Medical Inc. stock beat market expectations this quarterDay Trade & Fast Momentum Entry Tips - Newser
Outset Medical director Drexler sells $6.8k in stock By Investing.com - Investing.com Nigeria
Outset Medical director Drexler sells $6.8k in stock - Investing.com
What drives Outset Medical Inc stock priceEarnings Beat Highlights & Low Cost Investment Portfolio - earlytimes.in
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the Firm - Your Wyoming Link
Guidance Update: Can Outset Medical Inc. stock deliver strong Q4 earningsProduct Launch & Safe Swing Trade Setups - BỘ NỘI VỤ
Smart Money: Why Outset Medical Inc. stock could rally in 2025Quarterly Market Summary & Proven Capital Preservation Tips - moha.gov.vn
Winners Losers: Why Outset Medical Inc. stock is trending among retail tradersJuly 2025 Macro Moves & Verified Momentum Stock Ideas - moha.gov.vn
Is Outset Medical Inc. stock trading at a premium valuationJuly 2025 Fed Impact & Verified Entry Point Signals - BỘ NỘI VỤ
Why Outset Medical Inc. stock is a must watch in 2025Market Sentiment Report & Daily Momentum Trading Reports - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc.OM - PR Newswire
Why retail investors favor Outset Medical Inc. stock2025 Market Sentiment & Free Community Consensus Stock Picks - newser.com
Is Outset Medical Inc. stock attractive for growth ETFsTrade Entry Summary & Detailed Earnings Play Strategies - newser.com
Identifying reversal signals in Outset Medical Inc.2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Ranking Outset Medical Inc. among high performing stocks via toolsMarket Movement Recap & Low Risk Investment Opportunities - newser.com
How to forecast Outset Medical Inc. trends using time seriesJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
Outset Medical general counsel Brottem sells $1.7k in stock By Investing.com - Investing.com Australia
What the charts say about Outset Medical Inc. todayProduct Launch & Low Drawdown Momentum Trade Ideas - newser.com
How Outset Medical Inc. stock performs in high volatility marketsMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Outset Medical general counsel Brottem sells $1.7k in stock - Investing.com India
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan
Officer Brottem Surrenders 388 Of Outset Medical Inc [OM] - TradingView
Outset Medical appoints Renee Gaeta as CFO - MSN
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Trigg Leslie | Chair and CEO |
Nov 17 '25 |
Sale |
4.60 |
916 |
4,214 |
121,412 |
| Nash Marc | EVP Operations R&D & Service |
Nov 17 '25 |
Sale |
4.60 |
247 |
1,136 |
48,268 |
| Brottem John L. | General Counsel |
Nov 17 '25 |
Sale |
4.60 |
388 |
1,785 |
46,495 |
2.89%
4.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):